EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature

Fatma Eser, İmran Hasanoğlu, Bircan Kayaaslan, Ayşe Kaya Kalem, Şule Bilen, Gürdal Orhan, Rahmet Güner

The Journal of Infection in Developing Countries · 2024

DOI: 10.3855/jidc.18868 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Fatma Eser und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey. Hauptthemen laut MEDLINE: Botulinum Toxins, Botulinum Toxins, Type A, Botulism, Clostridium botulinum. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application. Case presentations: In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application.

Results

The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended.

Conclusions

Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum ToxinsBotulinum Toxins, Type ABotulismClostridium botulinumHumansBotulinum AntitoxinIatrogenic DiseaseParalysis

Stichwörter der Autor:innen

antitoxinbotulinum toxinbotulismiatrogenic

Substanzen

Botulinum AntitoxinBotulinum ToxinsBotulinum Toxins, Type A

Autor:innen und Institutionen

  • Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey.
  • University of Health Sciences, Ankara City Hospital, Department of Neurology, Ankara, Turkey.

Zitieren

APA

Eser, F., Hasanoğlu, İ., Kayaaslan, B., Kaya Kalem, A., Bilen, Ş., Orhan, G., & Güner, R. (2024). Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18868

Vancouver

Eser F, Hasanoğlu İ, Kayaaslan B, Kaya Kalem A, Bilen Ş, Orhan G, et al. Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.18868

BibTeX
@article{Eser2024,
  author = {Eser, Fatma and Hasanoğlu, İmran and Kayaaslan, Bircan and Kaya Kalem, Ayşe and Bilen, Şule and Orhan, Gürdal and Güner, Rahmet},
  title = {Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  doi = {10.3855/jidc.18868}
}
Kostenlos starten →